brain Logo
DE
  • 61

    Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2025
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2026
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • ESG-Strategie auf einen Blick
    • Environment
    • Social Responsibility
    • Corporate Management
    • Sustainability Reporting
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

29.08.2024
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
Finance
Show Article
22.08.2024
BRAIN Biotech AG launches the innovative technology platform MetXtra™ enabling unique enzyme solutions
Technology
Show Article
29.05.2024
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
Corporate
Show Article
28.05.2024
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
Finance Corporate
Show Article
16.04.2024
BRAIN Biotech AG takes next step to optimize group structure
Corporate
Show Article
14.03.2024
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
Technology
Show Article
12.03.2024
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
Corporate Finance
Show Article
07.03.2024
Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying
Technology Products
Show Article
29.02.2024
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
Finance Corporate
Show Article
  • 1
  • 2
  • 3
  • 4
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2026 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings